A resource for Italian biomedical research
The National Institute of Molecular Genetics (INGM) “Romeo and Enrica Invernizzi” is a research institute with focus on molecular genetics and on other methods of detection and diagnosis. INGM research began in 2007 and still continues inside the campus of the historic Policlinico Hospital, located in the very centre of Milan, in the “Romeo and Enrica Invernizzi” building. The Foundation has achieved significant scientific results in understanding the mechanisms of regulation of gene expression and interactions between the immune system and tumor cells.
As of today, INGM stands as a center of excellence in biomedical research both at national and international level.
55 PROJECTS
funded by national and international agencies and charities
17 MILLIONS DI EURO
won with competitive grants from national and international agencies and charities
MORE THAN 100 RESEARCHERS
work in our laboratories
News
Epigenetic editing against chronic hepatitis B: the study in Nature Biomedical Engineering with INGM’s contribution
Epigenetic editing against chronic hepatitis B: the study in Nature Biomedical Engineering with INGM's contribution CRMA-1001, developed by nChroma Bio together with SR-Tiget and INGM, silences viral DNA without cutting it. The first-in-human trial is already under way. A study published on 21 September in Nature Biomedical Engineering, featured on the Nature homepage, describes a new therapeutic strategy against [...]
The European Union funds research on the pandemic threats of Dengue (DENV) and West Nile Virus (WNV)
Strengthening the EU's capacity to combat DENV and WNV epidemics and pandemic threats is necessary to develop effective contingency plans. For this reason, the EU has funded the international project InFlaMe (Grant Agreement ID: 101191725), which is based on three pillars: 1) the clinical investigation of factors related to serious disease 2) the development of [...]
CheckmAb’s Immunotherapy in Collaboration with Boehringer Ingelheim Advances to Next Stage
CheckmAb’s Immunotherapy in Collaboration with Boehringer Ingelheim Advances to Next Stage Milan, Italy, February 4th 2025 CheckmAb S.r.l. announced today the successful achievement of the second milestone in the collaboration with Boehringer Ingelheim for the development of a monoclonal antibody (mAb) for cancer immunotherapy. Cancer immunotherapies have delivered meaningful therapeutic options to some cancer patients, [...]
EU funds research into causes and new therapies for multiple sclerosis
EU funds research into causes and new therapies for multiple sclerosis The progression of multiple sclerosis (MS) can usually be slowed down with medication, but a cure is currently not possible. It is now established that Epstein-Barr virus is involved in the development of MS. However, it is not known how the pathogen triggers the [...]
How can you help us
5×1000 (for italian residents)
Why donate your “5×1000” to INGM?
By donating your “5×1000” to INGM, you chose to back research and progress.
How to donate your “5×1000” to INGM?
Just sign in the provided line “Finanziamento della Ricerca Sanitaria” and write down the Institute fiscal code: 04157700964
Donations
All donations made in favour of our Foundation are tax-deductable to the full extent allowed by law.
IBAN: IT93 E084 4034 0700 0000 0240 450
INGM RESEARCH IS SUPPORTED BY
